They did testing for any virus or infection and all blood work came back negative.
The Dr’s suggested my son be moved to Children’s Hospital in Iowa City. It was there that the Dr’s discovered my son had encephalitis.
The Neurologist them came in and diagnosed him with ADEM DISEASE. From that point on my son spiraled downhill fast. He then went into respiratory failure, paralysis to the left side of his body, then stated having seizures. He was being treated with extremely high doses of steroids to combat the swelling in his brain. His case was so severe at this point that they had no other choice but to perform a craniotomy on the right side of his skull to help with brain swelling. His brain continued to swell and he ended up having a brain herniation. He was pronounced brain dead on August 14th 2018. My son was only 14 years old, bright, smart, handsome, awesome baseball player, he was on the honor roll and just 2 days from starting high school. He died as a direct result of the HPV VACCINE. My son should have never been given this medicine as he has NO CERVIX! This drug has not been proven to prevent cervical cancer. Japan named this drug in 2014 because of so many adverse reactions. My son Christopher Bunch and another child named Colton Berrett both died as a result of the HPV VACCINE.
There are hundreds of children that have died and thousands more that have been injured. On January 26th, the father of the boy, Elijah Eugene Mendoza-Bunch, wrote this via his Facebook page, So back on December 11th 2019 I sent an email to CEO Ken Frazier of Merck song to speak with him about the HPV VACCINE and how it killed my son and how it is destroying lives. Well here we are January 25th (the day I got it in the mail) and this is the response from Merck.... As you can see, the letter states that, “The safety and efficacy of our HPV vaccines have been established in a clinical development program that started more than 20 years ago and involved more than 49,000 individuals. Safety has continued to be evaluated after approval in multiple studies in several million people, in long-term follow up studies and through our extensive ongoing pharmacovigilance monitoring program in place throughout the world. Multiple independent scientific organizations and major regulatory and public health authorities, including the World Health Organization (WHO), the U.S. Centers for Disease Control and Prevention (CDC), and the U.S. Food and Drug Administration (FDA) have repeatedly evaluated the safety of HPV vaccines.
The results of these evaluations continue to be reassuring and reinforce the excellent safety profile of the vaccines.” A new study published in The Royal Society of Medicine is one of multiple studies over the years that has questioned the efficacy of the HPV vaccine.
The researchers conducted an appraisal of published phase 2 and 3 efficacy trials in relation to the prevention of cervical cancer and their analysis showed “the trials themselves generated significant uncertainties undermining claims of efficacy” in the data they used.
The researchers emphasized that “it is still uncertain whether human papillomavirus (HPV) vaccination prevents cervical cancer as trials were not designed to detect this outcome, which takes decades to develop.” The researchers point out that the trials used to test the vaccine may have “overestimated” the efficacy of the vaccine.
The study reviewed 35 published papers relating to 12 randomized blinded non-HPV vaccine-controlled Phase 2 and 3 trials of Gardasil and Cervarix conducted from 2001 to 2016 assessing efficacy against cervical cancer and its precursors. Researchers also examined 39 meta-analyses and systematic reviews of HPV vaccine efficacy. Another study published in 2013 in Current Pharmaceutical Design carried out a review of HPV vaccine pre- and post-licensure trials to assess the evidence of their effectiveness and safety.
They found that, HPV vaccine clinical trials design, and data interpretation of both efficacy and safety outcomes, were largely inadequate. Additionally, we note evidence of selective reporting of results from clinical trials (i.e., exclusion of vaccine efficacy figures related to study subgroups in which efficacy might be lower or even negative from peer-reviewed publications). Given this, the widespread optimism regarding HPV vaccines long-term benefits appears to rest on a number of unproven assumptions (or such which are at odds with factual evidence) and significant misinterpretation of available data. For example, the claim that HPV vaccination will result in approximately 70% reduction of cervical cancers is made despite the fact that the clinical trials data have not demonstrated to date that the vaccines have actually prevented a single case of cervical cancer (let alone cervical cancer death), nor that the current overly optimistic surrogate marker-based extrapolations are justified. Likewise, the notion that HPV vaccines have an impressive safety profile is only supported by highly flawed design of safety trials and is contrary to accumulating evidence from vaccine safety surveillance databases and case reports which continue to link HPV vaccination to serious adverse outcomes (including death and permanent disabilities). We thus conclude that further reduction of cervical cancers might be best achieved by optimizing cervical screening (which carries no such risks) and targeting other factors of the disease rather than by the reliance on vaccines with questionable efficacy and safety profiles. A study published in Clinical Rheumatology titled “Serious adverse events after HPV vaccination: a critical review of randomized and post-marketing case series” also brings up concerns: HPV vaccine randomized trials were identified in PubMed. Safety data were extracted. Post-marketing case series describing HPV immunization adverse events were reviewed. Most HPV vaccine randomized trials did not use inert placebo in the control group. Two of the largest randomized trials found significantly more severe adverse events in the tested HPV vaccine arm of the study.Is The Aluminum In HPV Vaccines The Issue? HPV vaccine injuries have happened. Jennifer Robi, a 24-year-old former athlete and scholar, was confined to a wheelchair after receiving her third Gardasil vaccine at the age of sixteen. She suffers from continual uncontrolled neuro/muscular contractions (jerking), postural orthostatic tachycardia syndrome (POTS), and many other symptoms of systemic autoimmune dysregulation. Jennifer’s attorney, Sol Ajalat, initially brought her case forward in Vaccine Injury Compensation Program and then, following a judgment in the program, elected to proceed in civil court. Since the Vaccine Injury Compensation Act (VICA) forbids recoveries for product defect or negligence, Ajalat brought Jennifer’s civil case under the theories that Merck committed fraud during its clinical trials and then failed to warn Jennifer (and, by implication, other injured girls) about the high risks and overstated benefits of the vaccine. You can read more about that story here. Another example I’ve written about in the past is a boy named Colton Berrett. You can read more about his case and watch an interview with him and his mother here. Vaccine injuries in general don’t seem to be as rare as it’s commonly claimed by our federal health regulatory agencies. This is exemplified by the National Childhood Vaccine Injury Act (NCVIA). To date, it’s paid approximately $4 billion to families with vaccine injured children.
These adverse reactions are the reason why the Japanese government, for example, suspended its recommendation of the HPV vaccine. It’s also important to note that these injuries only take into account 1 percent of all vaccine injured children, seeing as how 99 percent of vaccine injuries go completely unreported. (source) The HPV vaccine contains aluminum, and the potential issue with aluminum adjuvants in vaccines is that the aluminum does not exit the body, as opposed to the aluminum we take in from other sources like food and water. A study published in 2011 makes the issue quite clear: Aluminum is an experimentally demonstrated neurotoxin and the most commonly used vaccine adjuvant. Despite almost 90 years of widespread use of aluminum adjuvants, medical science’s understanding about their mechanisms of action is still remarkably poor.
There is also a concerning scarcity of data on toxicology and pharmacokinetics of these compounds. In spite of this, the notion that aluminum in vaccines is safe appears to be widely accepted. Experimental research, however, clearly shows that aluminum adjuvants have a potential to induce serious immunological disorders in humans. (source) I’ve written about this in depth multiple times, and to learn more about that you can refer to the most recent article I wrote on the subject that goes into more detail, or this one which is more specific to vaccines. Here’s another related article you may be interested in: Scientists Share Facts About Vaccines At World Health Organization Conference For Vaccine Safety. Vaccines are a controversial topic right now, and there are many scientists publishing research that question the official narrative that’s constantly put out by pharmaceutical companies and federal health regulatory agencies. This is why so many people are confused, because if vaccines were safe and effective, there wouldn’t be so much conflicting science on both ends of the spectrum. At the end of the day, I believe people should be able to do their own research and be free to make their own decisions. It doesn’t seem right to me for vaccinations to be forced upon anybody, and the concept of herd immunity is not without its flaws. Due to the pressure of mass censorship, we now have our own censorship-free, and ad-free on demand streaming network! You can stream conscious media 24/7 and enjoy mind-expanding interviews, original shows, and documentaries and guided programs. Click here to start a FREE 7-Day Trial and watch 100's of hours of conscious media that you won't see anyw.
Read the full article at the original website